Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Watching ‘Home Alone’ with the kids this holiday season? Brace yourself for '6-7.' - 2An Extended period of Voyaging Carefully: the World with Reason
- 35 VIP Voice Exhibitions in Energized Movies
- 4the Kinds of Thailand: Decision in favor of Your Number one Thai Dish!
- 5How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- 'The best gift ever': Baby is born after the rarest of pregnancies, defying all odds
- 10 Hints and Deceives to Expand Cell Phone Information Use: Capitalize on Your Information
- Instructions to Explore the Therapy Choices for Cellular breakdown in the lungs
- Newly discovered link between traumatic brain injury in children and epigenetic changes could help personalize treatment for recovering kids
- Becoming Familiar with an Unknown dialect: My Language Learning Excursion
- Al-Sharaa denies he called for 80% of Syrians to return from Germany
- Which Film Has the Incomparable Melodic Score?
- The Most Astonishing Arising Advancements to Watch
- Flu is rising rapidly, driven by a new variant. Here's what to know
